Sight Sciences, Inc. (SGHT)
NASDAQ: SGHT · IEX Real-Time Price · USD
7.61
-0.05 (-0.65%)
At close: Jul 19, 2024, 12:00 AM
7.55
-0.06 (-0.79%)
Pre-market: Jul 22, 2024, 8:22 AM EDT
Sight Sciences Employees
Sight Sciences had 214 employees as of December 31, 2023. The number of employees decreased by 36 or -14.40% compared to the previous year.
Employees
214
Change (1Y)
-36
Growth (1Y)
-14.40%
Revenue / Employee
$380,822
Profits / Employee
-$255,822
Market Cap
378.65M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 214 | -36 | -14.40% |
| Dec 31, 2022 | 250 | 38 | 17.92% |
| Dec 31, 2021 | 212 | 43 | 25.44% |
| Dec 31, 2020 | 169 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Organogenesis Holdings | 862 |
| Revance Therapeutics | 597 |
| uniQure | 480 |
| Talkspace | 472 |
| AxoGen | 428 |
| Lyell Immunopharma | 224 |
| TScan Therapeutics | 154 |
| Lexeo Therapeutics | 58 |
SGHT News
- 3 days ago - Sight Sciences to Report Second Quarter Financial Results on August 1, 2024 - GlobeNewsWire
- 5 weeks ago - Sight Sciences Announces the Release of its First Sustainability Report - GlobeNewsWire
- 7 weeks ago - Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Improved Signs and Symptoms of Dry Eye Disease for TearCare Patients Crossed Over from Restasis - GlobeNewsWire
- 7 weeks ago - Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI® Across Mild, Moderate, and Advanced Glaucoma - GlobeNewsWire
- 2 months ago - Sight Sciences Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Financial Guidance - GlobeNewsWire
- 3 months ago - Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery - GlobeNewsWire
- 3 months ago - Sight Sciences to Report First Quarter Financial Results on May 2, 2024 - GlobeNewsWire
- 3 months ago - Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 - GlobeNewsWire